Cognitive Behavior Therapy (CBT)-Based Group Intervention to Reduce Inflammation in Older People With HIV
CHAMP
Feasibility and Acceptability of a Cognitive Behavioral Therapy (CBT)-Based Group Intervention to Reduce Inflammation in Older People With HIV
2 other identifiers
interventional
50
1 country
1
Brief Summary
In this study, the investigators will assess the feasibility and acceptability of an evidence-based CBT group intervention, developed for older people with HIV, and research methods in a pilot randomized controlled trial including 50 older people with HIV as participants. The evidence-based CBT intervention has been developed and utilized in three clinical groups to date initiated and led by Dr. Batchelder (PI) in the Behavioral Medicine program at MGH. The 12-week intervention program proposed leverages evidence-based traditional and contemporary CBT strategies, with the goal of improving the psychological and physical functioning of older people with HIV by providing education and support to learn strategies to: a.) better manage stressors associated with HIV and aging (e.g., multi-morbidity), and b.) increase health-promoting behaviors (e.g., physical activity).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 17, 2022
CompletedStudy Start
First participant enrolled
June 20, 2022
CompletedFirst Posted
Study publicly available on registry
June 28, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2025
CompletedDecember 8, 2025
December 1, 2024
1.4 years
June 17, 2022
December 1, 2025
Conditions
Outcome Measures
Primary Outcomes (2)
Acceptability of the CBT group intervention
Acceptability will be assessed with a satisfaction evaluation survey previously used with similar samples, modeled after the Client Satisfaction Questionnaire (CSQ-8).
12-week follow-up
Feasibility of the CBT group intervention
Feasibility data will consist of attendance patterns. Feasibility of assessment will be the completion of at least 75% of scheduled group sessions.
12-week follow-up
Secondary Outcomes (5)
Changes in psychological distress
Baseline and at 12-week follow-up appointments.
Feasibility of the CBT intervention
12-week follow-up
Feasibility of the CBT intervention
12-week follow-up
Feasibility of the CBT group intervention
12-week follow-up
Acceptability of the CBT group intervention
Weekly
Study Arms (2)
CBT Group
EXPERIMENTALThis 12-week intervention program leverages evidence-based traditional and contemporary CBT strategies, with the goal of improving the psychological and physical functioning of older people with HIV by providing education and support to learn strategies to: a.) better manage stressors associated with HIV and aging (e.g., treatment access and engagement, and multi-morbidity), and b.) increase health-promoting behaviors (e.g., physical activity).
Information-only Group
EXPERIMENTALParticipants in the control group will receive a one-time trifold brochure titled "HIV: 50 Years or Older."
Interventions
The topics covered in group CBT sessions are: 1.) Domains of Healthy Aging; 2.) Stress and anxiety; 3.) Adherence and Engagement in Primary/Preventative Care; 4.) Depression and Distress; 5.) Physical Activity; 6.) Stigma/Self-Compassion; 7.) Substance Use; 8.) Acceptance of Uncertainty and Uncomfortable Emotions; 9.) Diet; 10.) Behavioral Activation; 11.) Frailty and Memory/Cognition; and 12.) Wrap-Up and Maintaining Gains.
Participants in the education only group will receive a one-time trifold brochure titled "HIV: 50 Years or Older. This brochure contains information on the prevalence of HIV among people aged 50 and older, defines medication adherence and drug resistance, encourages physical activity and proper nutrition, and addresses the health risk behavior of tobacco-smoking for people living with HIV. Participants receive one brochure in the information-only group.
Eligibility Criteria
You may qualify if:
- HIV+ with an undetectable test result within the last 12 months; willing to provide printed or online version of test result for confirmation
- years of age or older
- On effective ART; willing to provide ART-related health records or prescriptions for confirmation
- Fluent in English (speaking and reading)
- Willing and able to provide informed consent
- Psychiatrically stable based on clinical interview
You may not qualify if:
- HIV-
- Unable to provide undetectable HIV test result within the last 12 months
- Not on effective ART
- \<50 years old
- Unable to read and write in English
- Unable to provide informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
One Bowdoin Square, Floor 7
Boston, Massachusetts, 02114, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator, Assistant Professor, Staff Psychologist
Study Record Dates
First Submitted
June 17, 2022
First Posted
June 28, 2022
Study Start
June 20, 2022
Primary Completion
December 1, 2023
Study Completion
February 28, 2025
Last Updated
December 8, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share